Flynn Daniel Lee 4
4 · Deciphera Pharmaceuticals, Inc. · Filed Jan 20, 2022
Insider Transaction Report
Form 4
Flynn Daniel Lee
Chief Scientific Officer
Transactions
- Award
Common Stock
2022-01-18+20,500→ 49,232 total - Award
Stock Option (Right to Buy)
2022-01-18+82,000→ 82,000 totalExercise: $8.27Exp: 2032-01-17→ Common Stock (82,000 underlying)
Holdings
- 91,020(indirect: By Trust)
Common Stock
- 230,435(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The reporting person was awarded 20,500 Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock. The RSUs shall vest in three (3) equal annual installments on each of January 15, 2023, January 15, 2024 and January 15, 2025.
- [F2]This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. The option shall vest in equal monthly installments over four (4) years, beginning on February 18, 2022.